Erectile dysfunction: A review and herbs used for its treatment
DOI:
https://doi.org/10.22377/ijgp.v6i2.246Abstract
Erectile dysfunction (ED) or male impotence is defined as the inability to have or sustain an erection long enough to have ameaningful sexual intercourse. ED tends to occur gradually until the night time or early morning erections cease altogether or are
so flaccid that successful intercourse does not occur. Sexual health is an important determinant of quality of life. Today, millions of men, young and old, suffer from ED due to high levels of synthetic hormones (known as Xenoestrogens) in our diet/environment; nutritionally imbalanced diet resulting from poor quality of produces; and extremely low levels of testosterone. To overcome the problem of sexual (or) ED various natural aphrodisiac potentials are preferred. The present review discusses about aphrodisiac potential of plants, its biological source, common name, part used and references, which are helpful for researchers to develop new
aphrodisiac formulations.
Key words: Aphrodisiac, erectile dysfunction, Phosphodiesterease
Downloads
References
Ackerman M, Rajiah K, Veettil SK, Kumar S, Mathew EM.
Impotence: Help for Erectile Dysfunction Patient Care. Victoria
Island, Lagos: Scientific Research and Essays; 1994. p.22-56.
Mulligan T. Geriatric Sexual Dysfunction: A Rational Approach to
a Sensitive Topic. 730 East Broad Street P.O. Box 980229 Richmond,
VA 23298-0229: Virginia Geriatric Education Center; 1990.
Kahn J. Smoking May Increase Risk of Impotence Medical Tribune.
Am J Epidemiol 1995;5:19.
Guay AT, Spark RF, Bansal S, Cunningham GR, Goodman NF,
Nankin HR, et al. American Association of Clinical Endocrinologists
medical guidelines for clinical practice for the evaluation and
treatment of male sexual dysfunction: A couple’s problem–2003
update. Endocr Pract 2003;9:77-95.
Salmon PH. Psychosexual dysfunction in chronic renal failure: An
overview. Proc EDTNA. Pharmacogn Rev 1983;12:209-12.
Kaplan HS. Erotic obsession: Relationship to hypoactive sexual desire
disorder and paraphilia. Am J Psychiatry 1996;153(7 Suppl):30-41.
Bosch RJ, Benard F, Aboseif SR, Stief CG, Lue TF, Tanagho EA.
Penile detumescence: Characterization of three phases. J Urol
;146:867-71.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ,
McKinlay JB. Impotence and its medical and psychosocial
correlates: Results of the Massachusetts Male Aging Study. J Urol
;151:54-61.
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M,
Engelmann U. Epidemiology of erectile dysfunction: Results of
the ‘Cologne Male Survey’. Int J Impot Res 2000;12:305-11.
Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB,
McKinlay JB. Modifiable risk factors and erectile dysfunction: Can
lifestyle changes modify risk. Urology 2000;56:302-6.
Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R,
Waters WB, et al. Erectile dysfunction after radical prostatectomy:
Hemodynamic profiles and their correlation with the recovery of
erectile function. J Urol 2002;167:1371-5.
Wespes E, Schulman C. Venous impotence: Pathophysiology,
diagnosis and treatment. J Urol 1993;149:1238-45.
Hatzichristou D, Rosen RC, Broderick G, Clayton A, Cuzin B,
Derogatis L, et al. Clinical evaluation and management strategy
for sexual dysfunction in men and women. J Sex Med 2004;1:49-57.
Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB,
McKinlay JB. Modifiable risk factors and erectile dysfunction: Can
lifestyle changes modify risk. Urology 2000;56:302-6.
Bianco F, Kattan M, Eastham J, Scardino PT, Mulhall JP. Surgeon
and surgical volume as predictors of erectile function outcomes
following radical prostatectomy. J Sex Med 2004;1:34.
Padma-Nathan H, McCullough AR, Levine LA, Lipschultz LI,
Siegel R, Montorsi F, et al. Randomized, double-blind, placebocontrolled
study of postoperative nightly sildenafil citrate for the
prevention of erectile dysfunction after bilateral nerve-sparing
radical prostatectomy. Int J Impot Res 2008;20:479-86.
Brock G, Nehra A, Lipshultz LI, Karlin GS, Gleave M, Seger M,
et al. Safety and efficacy of vardenafil for the treatment of men
with erectile dysfunction after radical retropubic prostatectomy.
J Urol 2003;170:1278-83.
Montague DK. Penile prosthesis implantation for end-stage erectile
dysfunction after radical prostatectomy. Rev Urol 2005;7 Suppl
:S51-7.
Morales A, Heaton JP. Hormonal erectile dysfunction. Evaluation
and management. Urol Clin North Am 2001;28:279-88.
Wespes E, Wildschutz T, Roumeguere T, Schulman CC. The place
of surgery for vascular impotence in the third millennium. J Urol
;170:1284-6.
Stuckey BG, Jadzinsky MN, Murphy LJ, Montorsi F, Kadioglu A,
Fraige F, et al., Deerochanawong C. Sildenafil citrate for treatment
of erectile dysfunction in men with type 1 diabetes: Results of a
randomized controlled trial. Diabetes Care 2003;26:279-84.
Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V,
et al. Efficacy and safety of tadalafil for the treatment of erectile
dysfunction: Results of integrated analyses. J Urol 2002;168:1332-6.
Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T,
Taylor T. Vardenafil, a new phosphodiesterase type 5 inhibitor,
in the treatment of erectile dysfunction in men with diabetes:
A multicenter double-blind placebo-controlled fixed-dose study.
Diabetes Care 2003;26:777-83.
Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-
Mboussa A, et al. Evaluation of the efficacy and safety of once-aday
dosing of tadalafil 5 mg and 10 mg in the treatment of erectile
dysfunction: Results of a multicenter, randomized, double-blind,
placebo-controlled trial. Eur Urol 2006;50:351-9.
Mirone V, Costa P, Damber JE, Holmes S, Moncada I, Van
Ahlen H, et al. An evaluation of an alternative dosing regimen
with tadalafil, 3 times/week, for men with erectile dysfunction:
SURE study in 14 European countries. Eur Urol 2005;47:846-54;
discussion 854.
Burnett AL. Novel nitric oxide signaling mechanisms regulate the
erectile response. Int J Impot Res 2004;16 Suppl 1:S15-9.
Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G,
Carrier S, et al. Pharmacotherapy for erectile dysfunction. J Sex
Med 2004;1:128-40.
Hong B, Ji YH, Hong JH, Nam KY, Ahn TY. A double-blind
crossover study evaluating the efficacy of korean red ginseng in
patients with erectile dysfunction: A preliminary report. J Urol
;168:2070-3.
Hong B, Ji YH, Hong JH, Nam KY, Ahn TY. A double-blind
crossover study evaluating the efficacy of korean red ginseng in
patients with erectile dysfunction: A preliminary report. J Urol
;168:2070-3.
Joy PP, Thomas J, Mathew S, Skaria PB, Medicinal Plants. Thrissur,
Kerala: Kerala Agricultural University, Aromatic and Medicinal
Plants Research Station; 1998.
Satyavati GV, Raina MK, Sharma M, Medicinal Plants of India.
Vol. 1. New Delhi: Ind. Council on Med. Res; 1976.
Jahan S, Rasool S, Khan MA, Ahmad M, Zafar M, Abbasi AM.
Antifertility effects of ethanolic seed extract of Abrus precatorius
L. on sperm production and DNA integrity in adult male mice.
Indian J Tradit Knowl 2005;4:317-24.
Maiti S, Geetha KA. Horticulture Floriculture Medicinal and
Aromatic Plants in India; 2007.
Prasanth PR, Kumar A. Ethno-medico botany of medicinal plants
for the treatment of diabetic activity in Krishna district, Andhra
Pradesh. Int J Pharm Res Dev 2008;9:1-9.
Yakubu MT, Adewmi MA, Oladiji TA. Male sexual dysfunction
and methods used in assessing medicinal plants with aphrodisiac
potentials. Res J Med Plants 2008;2:66-73.
Sumalatha K, Kumar SA, Lakshmi SM. Review on Natural
Aphrodisiac potentials to treat Sexual dysfunction. Int J Pharm
Ther 2010;1:10-8.
Nocerino E, Amato M, Izzo AA. The aphrodisiac and adaptogenic
properties of ginseng. Fitoterapia 2000;71 Suppl 1:S1-5.
Kumar S, Madaan R, Sharma A. Evaluation of Aphrodisiac Activity
of Turnera aphrodisiaca, Int J Pharmacognosy Phytochem Res
;1:1-4.
Singh KP, Kumar V, Tiwari KR, Sharma A, Rao CV, Singh RH.
Medico-Ethnobotany of 'Chatara' Block of District Sonebhadra,
Uttar Pradesh, India. Adv Biol Res 2010;4:65-80.
Fabricant SD, Farnsworth RN. The value of Plants Used in
Traditional Medicine for Drug Discovery. Environ Health Perspect
;109 Suppl 1:69-75.
Welt K, Weiss J, Koch S, Fitzl G. Protective effects of Ginkgo
biloba extract EGb 761 on the myocardium of experimentally
diabetic rats. II. Ultrastructural and immunohistochemical
investigation on microvessels and interstitium. Exp Toxicol
Pathol 1999;51:213-22.
Available from: http://www.ayurhelp.com/plants/tribulusterrestris.
htm. [Last accessed on 2011 Nov 4].
Gauthaman K, Adaikan PG, Prasad RN. Aphrodisiac properties of
Tribulus Terrestris extract (Protodioscin) in normal and castrated
rats. Life Sci 2002;71:1385-96.
Tomova M, Gyulemetova R. Steroidsapogenine, Tribulus terrestris
Linn: A review article. Planta Med 1978;34:188-91.
Frotan MH, Acharya SB. Pharmacological studies of shilajit. Indian
J Pharmacol 1984;16:45.
Parekar S. Estrogenic activity of Mucuna pruriens in swiss albino
mice. Int Res J Pharm 2011;2:191-3.
Available from: http://www.science20.com/humboldt_fellow_
and_science/blog/asparagus_racemosus_willd_has_medicinal_
properties. [Last accessed on 2011 Nov 4].
Available from: http://thamilar-nalasevai.info/Media/healthcare/
Male-Support_eng.pdf. [Last accessed on 2011 Nov 4].
Available from: http://www.himalayahealthcare.com/herbfinder/h_
ipomoea.htm. [last accessed on 2011 Nov 4].
Available from: http://enchantingkerala.org/ayurveda/ayurvedicmedicinal
plants/akkikaruka.php. [Last accessed on 2011 Nov 4].
Available from: http://users.skynet.be/bertram.zambiafoundation/
Afbeeldingen/Literature_revue_Pyrethrum_root.pdf. [Last
accessed on 2011 Nov 4].
Guohua H, Yanhua L, Rengang M, Dongzhi W, Zhengzhi M,
Hua Z. Aphrodisiac properties of Allium tuberosum seeds extract.
J Ethnopharmacol 2009;122:579-82.
Available from: http://www.inharmonyherbs.com/articles/95-
herbal-aphrodisiacs.html. [Last accessed on 2011 Nov 4].
